About the Authors
- Claus Rieker
-
Affiliation Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
- Kumlesh K. Dev
-
Affiliation Department of Physiology, School of Medicine, Trinity College Dublin, Dublin, Ireland
- Katja Lehnhoff
-
Affiliation Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
- Samuel Barbieri
-
Affiliation Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
- Iwona Ksiazek
-
Current address: Department of Neuroscience, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
Affiliation Neurobiology Biozentrum, University of Basel, Basel, Switzerland
- Sabine Kauffmann
-
Affiliation Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
- Simone Danner
-
Affiliation Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
- Heinrich Schell
-
Affiliation Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tübingen, Tübingen, Germany
- Cindy Boden
-
Affiliation Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tübingen, Tübingen, Germany
- Markus A. Ruegg
-
Affiliation Neurobiology Biozentrum, University of Basel, Basel, Switzerland
- Philipp J. Kahle
-
Affiliation Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tübingen, Tübingen, Germany
- Herman van der Putten
-
Affiliation Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
- Derya R. Shimshek
-
* E-mail: derya.shimshek@novartis.com
Affiliation Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
Competing Interests
Claus Rieker, Katja Lehnhoff, Samuel Barbieri, Sabine Kauffmann, Simone Danner Herman van der Putten and Derya Shimshek are employees of Novartis Pharma AG. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: DRS IK MAR PJK HvdP. Performed the experiments: KL SB IK SK SD HS CB DRS. Analyzed the data: IK MAR PJK DRS. Contributed reagents/materials/analysis tools: CR. Wrote the paper: CR KKD PJK HvdP DRS.